Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Virol ; 85(14): 6822-31, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21593179

RESUMEN

The absence of interleukin-10 (IL-10), a potent anti-inflammatory cytokine results in increased immune-mediated demyelination in mice infected with a neurotropic coronavirus (recombinant J2.2-V-1 [rJ2.2]). Here, we examined the therapeutic effects of increased levels of IL-10 at early times after infection by engineering a recombinant J2.2 virus to produce IL-10. We demonstrate that viral expression of IL-10, which occurs during the peak of virus replication and at the site of disease, enhanced survival and diminished morbidity in rJ2.2-infected wild-type B6 and IL-10(-/-) mice. The protective effects of increased IL-10 levels were associated with reductions in microglial activation, inflammatory cell infiltration into the brain, and proinflammatory cytokine and chemokine production. Additionally, IL-10 increased both the frequency and number of Foxp3(+) regulatory CD4 T cells in the infected central nervous system. Most strikingly, the ameliorating effects of IL-10 produced during the first 5 days after infection were long acting, resulting in decreased demyelination during the resolution phase of the infection. Collectively, these results suggest that the pathogenic processes that result in demyelination are initiated early during infection and that they can be diminished by exogenous IL-10 delivered soon after disease onset. IL-10 functions by dampening the innate or very early T cell immune response. Further, they suggest that early treatment with IL-10 may be useful adjunct therapy in some types of viral encephalitis.


Asunto(s)
Coronavirus/genética , Enfermedades Desmielinizantes/prevención & control , Encefalomielitis/prevención & control , Interleucina-10/fisiología , Enfermedad Aguda , Animales , Secuencia de Bases , Enfermedad Crónica , Cartilla de ADN , Enfermedades Desmielinizantes/inmunología , Encefalomielitis/inmunología , Citometría de Flujo , Interleucina-10/genética , Ratones , Proteínas Recombinantes/metabolismo , Recombinación Genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
2.
J Invest Dermatol ; 132(5): 1425-34, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22318381

RESUMEN

One strategy adopted by vaccinia virus (VV) to evade the host immune system is to encode homologs of TNF receptors (TNFRs) that block TNF-α function. The response to VV skin infection under conditions of TNF-α deficiency, however, has not been reported. We found that TNFR1-/- mice developed larger primary lesions, numerous satellite lesions, and higher skin virus levels after VV scarification. Following their recovery, VV-scarified TNFR1-/- mice were fully protected against challenge with a lethal intranasal dose of VV, suggesting these mice had developed an effective memory immune response. A functional systemic immune response was further demonstrated by enhanced production of VV-specific IFN-γ and VV-specific CD8(+) T cells in spleens and draining lymph nodes. Interestingly, bone marrow (BM)-reconstitution studies using wild-type (WT) BM in TNFR1-/- host mice, but not TNFR1-/- BM in WT host mice, reproduced the original results seen in TNFR1-/- mice, indicating that TNFR1 deficiency in resident skin cells, rather than hematopoietic cells, accounts for the impaired cutaneous immune response. Our data suggest that lack of TNFR1 leads to a skin-specific immune deficiency, and that resident skin cells have a crucial role in mediating an optimal immune defense to VV cutaneous infection via TNF-α/TNFR1 signaling.


Asunto(s)
Anticuerpos Antivirales/sangre , Linfocitos T CD8-positivos , Receptores Tipo I de Factores de Necrosis Tumoral/inmunología , Piel/inmunología , Factor de Necrosis Tumoral alfa/inmunología , Virus Vaccinia/inmunología , Vaccinia/inmunología , Animales , Inmunidad Innata , Inmunoglobulina G/sangre , Interferón gamma/metabolismo , Recuento de Linfocitos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores Tipo I de Factores de Necrosis Tumoral/deficiencia , Piel/virología , Vaccinia/patología , Carga Viral
3.
J Sch Nurs ; 24(6): 417-24, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19114472

RESUMEN

This study investigated the association between sleep deprivation and enrollment in Advanced Placement (AP) and/or college courses among high school students. Approximately 4,000 surveys were distributed, and 2,197 completed surveys were returned from students in Grades 9 to 12 at 15 high schools in Iowa. Findings indicated the majority of high school students were sleep deprived. Sleep deprivation was significantly associated with enrollment in AP/college courses. Results indicated that enrollment in AP/college courses had a greater impact on younger students than older students. Compared with non-AP/college course takers, AP/college course takers slept approximately 20 minutes less per night. Specifically, 9th- and 10th-grade AP/college course takers slept approximately 1 hour less and 40 minutes less, respectively. In addition, students enrolled in two or more AP/college classes received 1 hour less and 30 minutes less among 10th and 11th graders, respectively. These results provide useful information on adolescent sleep patterns for school nurses.


Asunto(s)
Escolaridad , Privación de Sueño/epidemiología , Estudiantes/psicología , Adolescente , Femenino , Encuestas Epidemiológicas , Humanos , Iowa/epidemiología , Masculino , Análisis Multivariante , Análisis de Regresión , Servicios de Enfermería Escolar , Privación de Sueño/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA